These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32369857)

  • 1. Statins and Major Adverse Limb Events in Patients with Peripheral Artery Disease: A Systematic Review and Meta-Analysis.
    Pastori D; Farcomeni A; Milanese A; Del Sole F; Menichelli D; Hiatt WR; Violi F
    Thromb Haemost; 2020 May; 120(5):866-875. PubMed ID: 32369857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis.
    Kokkinidis DG; Arfaras-Melainis A; Giannopoulos S; Katsaros I; Jawaid O; Jonnalagadda AK; Parikh SA; Secemsky EA; Giri J; Kumbhani DJ; Armstrong EJ
    Vasc Med; 2020 Apr; 25(2):106-117. PubMed ID: 31964311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Statin Therapy and Dose on Cardiovascular and Limb Outcomes in Peripheral Arterial Disease: A Systematic Review and Meta-analysis.
    Sofat S; Chen X; Chowdhury MM; Coughlin PA
    Eur J Vasc Endovasc Surg; 2021 Sep; 62(3):450-461. PubMed ID: 34389230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin use improves limb salvage after intervention for peripheral arterial disease.
    Parmar GM; Novak Z; Spangler E; Patterson M; Passman MA; Beck AW; Pearce BJ
    J Vasc Surg; 2019 Aug; 70(2):539-546. PubMed ID: 30718113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins and statin intensity in peripheral artery disease.
    Sagris M; Katsaros I; Giannopoulos S; Rosenberg RD; Altin SE; Rallidis L; Mena-Hurtado C; Armstrong EJ; Kokkinidis DG
    Vasa; 2022 Jul; 51(4):198-211. PubMed ID: 35673949
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry.
    Stavroulakis K; Borowski M; Torsello G; Bisdas T;
    J Vasc Surg; 2017 Nov; 66(5):1534-1542. PubMed ID: 28807382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin use in patients with peripheral arterial disease.
    Harris SK; Roos MG; Landry GJ
    J Vasc Surg; 2016 Dec; 64(6):1881-1888. PubMed ID: 27871503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Statin Therapy With Major Adverse Cardiovascular and Limb Outcomes in Patients With End-stage Kidney Disease and Peripheral Artery Disease Receiving Maintenance Dialysis.
    Lo HY; Lin YS; Lin DS; Lee JK; Chen WJ
    JAMA Netw Open; 2022 Sep; 5(9):e2229706. PubMed ID: 36048442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease.
    Arya S; Khakharia A; Binney ZO; DeMartino RR; Brewster LP; Goodney PP; Wilson PWF
    Circulation; 2018 Apr; 137(14):1435-1446. PubMed ID: 29330214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
    Armstrong EJ; Chen DC; Westin GG; Singh S; McCoach CE; Bang H; Yeo KK; Anderson D; Amsterdam EA; Laird JR
    J Am Heart Assoc; 2014 Apr; 3(2):e000697. PubMed ID: 24721799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a Guideline-Recommended Risk-Reduction Program to Improve Cardiovascular and Limb Outcomes in Patients With Peripheral Arterial Disease.
    Hussain MA; Al-Omran M; Mamdani M; Eisenberg N; Premji A; Saldanha L; Wang X; Verma S; Lindsay TF
    JAMA Surg; 2016 Aug; 151(8):742-50. PubMed ID: 27050566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cohort Study Examining the Association of Immunosuppressant Drug Prescription With Major Adverse Cardiovascular and Limb Events in Patients With Peripheral Artery Disease.
    Golledge J; Velu R; Quigley F; Jenkins J; Singh TP
    Ann Vasc Surg; 2022 Jan; 78():310-320. PubMed ID: 34537348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization.
    Desai K; Han B; Kuziez L; Yan Y; Zayed MA
    J Vasc Surg; 2021 Feb; 73(2):711-721.e3. PubMed ID: 32891809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk).
    Bonaca MP; Nault P; Giugliano RP; Keech AC; Pineda AL; Kanevsky E; Kuder J; Murphy SA; Jukema JW; Lewis BS; Tokgozoglu L; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    Circulation; 2018 Jan; 137(4):338-350. PubMed ID: 29133605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Goto S; Ohman EM; Elbez Y; Sritara P; Baumgartner I; Banerjee S; Creager MA; Bhatt DL;
    Eur Heart J; 2014 Nov; 35(41):2864-72. PubMed ID: 24585266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin Therapy Reduces Future Risk of Lower-Limb Amputation in Patients With Diabetes and Peripheral Artery Disease.
    Hsu CY; Chen YT; Su YW; Chang CC; Huang PH; Lin SJ
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2373-2381. PubMed ID: 28398564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on Mortality and Cardiovascular Events of Adherence to Guideline-Recommended Therapy 4 Years after Lower Extremity Arterial Revascularization.
    Thiney M; Della Schiava N; Ecochard R; Feugier P; Lermusiaux P; Millon A; Long A
    Ann Vasc Surg; 2018 Oct; 52():138-146. PubMed ID: 29777848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of lower extremity peripheral artery disease in veterans.
    Willey J; Mentias A; Vaughan-Sarrazin M; McCoy K; Rosenthal G; Girotra S
    J Vasc Surg; 2018 Aug; 68(2):527-535.e5. PubMed ID: 29588132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58.
    Bonaca MP; Wiviott SD; Zelniker TA; Mosenzon O; Bhatt DL; Leiter LA; McGuire DK; Goodrich EL; De Mendonca Furtado RH; Wilding JPH; Cahn A; Gause-Nilsson IAM; Johanson P; Fredriksson M; Johansson PA; Langkilde AM; Raz I; Sabatine MS
    Circulation; 2020 Aug; 142(8):734-747. PubMed ID: 32795086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.